Physician profile
Ryan Brooks Viets
NPI 1568617108
$4,266.33
in general payments reported to CMS, 2019-2025
7 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,546 · 2020: $114 · 2021: $169 · 2022: $670 · 2023: $366 · 2024: $192 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,091.69 | 2019-2025 | Penumbra Coil 400, Penumbra System, Red 72 |
| Microvention, INC. | $360.35 | 2019-2022 | |
| Depuy Synthes Sales INC. | $317.30 | 2019-2023 | Emboguard, Trufill |
| Stryker Corporation | $217.21 | 2022-2024 | Ivas, Spinejack, Autoplex |
| Medtronic, INC. | $162.85 | 2022-2024 | Axium Primetm |
| Vasorum USA INC. | $94.67 | 2023 | Celt Acd |
| Life Molecular Imaging LTD | $22.26 | 2025 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Viets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.